{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:02:06Z","timestamp":1791172926711,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,15]]},"DOI":"10.1097\/qad.0b013e32832995fa","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T15:17:53Z","timestamp":1242919073000},"page":"929-939","source":"Crossref","is-referenced-by-count":130,"title":["HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial"],"prefix":"10.1097","volume":"23","author":[{"given":"Alexandra","family":"Calmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Gayet-Ageron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasiwimol","family":"Ubolyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiat","family":"Ruxungtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hirschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintanat","family":"Ananworanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(99)01122-8","article-title":"Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study","volume":"353","author":"Ledergerber","year":"1999","journal-title":"Lancet"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","article-title":"Changes in causes of death among adults infected by HIV between 2000 and 2005: the \u2018Mortalit\u00e9 2000 and 2005\u2019 surveys (ANRS EN 19 and Mortavic)","volume":"48","author":"Lewden","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2796.2006.01761.x","article-title":"HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy","volume":"261","author":"Sterne","year":"2007","journal-title":"J Intern Med"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy","volume":"52","author":"Torriani","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/QAD.0b013e328303be2a","article-title":"Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumption of antiretroviral therapy","volume":"22","author":"Papasavvas","year":"2008","journal-title":"AIDS"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/ken395","article-title":"Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis","volume":"48","author":"Montecucco","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cca.2008.09.018","article-title":"Soluble P-selectin as a marker of in vivo platelet activation","volume":"399","author":"Ferroni","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R13-8-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s005990070001","article-title":"Endogenous levels of C-C chemokines MIP-1alpha, MIP-1beta, and RANTES do not reflect the disease course in HIV-seropositive individuals","volume":"30","author":"Kreuzer","year":"2000","journal-title":"Int J Clin Lab Res"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1152\/physiolgenomics.00104.2007","article-title":"Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease","volume":"31","author":"Ardigo","year":"2007","journal-title":"Physiol Genomics"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk","volume":"28","author":"Aukrust","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-0691.2004.01033.x","article-title":"Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection","volume":"11","author":"Montes de Oca Arjona","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"R17-8-20210130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-8518-3-3","article-title":"Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection","volume":"3","author":"Brown","year":"2005","journal-title":"J Immune Based Ther Vaccines"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/euhj.2001.2780","article-title":"Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis","volume":"23","author":"Kell","year":"2002","journal-title":"Eur Heart J"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/CIA.S2706","article-title":"New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor","volume":"3","author":"Montecucco","year":"2008","journal-title":"Clin Interv Aging"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1536\/ihj.49.391","article-title":"Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity","volume":"49","author":"Kuo","year":"2008","journal-title":"Int Heart J"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2249.1999.00865.x","article-title":"IL-10 in HIV infection: increasing serum IL-10 levels with disease progression \u2013 down-regulatory effect of potent antiretroviral therapy","volume":"116","author":"Stylianou","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R23-8-20210130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2006.06.016","article-title":"Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach","volume":"193","author":"Tziakas","year":"2007","journal-title":"Atherosclerosis"},{"key":"R24-8-20210130","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/QAD.0b013e3280adc91e","article-title":"The role of adipokines in relation to HIV lipodystrophy","volume":"21","author":"Sweeney","year":"2007","journal-title":"AIDS"},{"key":"R25-8-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ijo.2008.224","article-title":"Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study","volume":"33","author":"Soderberg","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"R26-8-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ncpcardio1398","article-title":"Protective vascular and myocardial effects of adiponectin","volume":"6","author":"Goldstein","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"R27-8-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(06)69153-8","article-title":"CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial","volume":"368","author":"Ananworanich","year":"2006","journal-title":"Lancet"},{"key":"R28-8-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An updated coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"R29-8-20210130","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R30-8-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/338572","article-title":"Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1","volume":"185","author":"Wolf","year":"2002","journal-title":"J Infect Dis"},{"key":"R31-8-20210130","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/CIRCULATIONAHA.107.717926","article-title":"Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study","volume":"116","author":"Golledge","year":"2007","journal-title":"Circulation"},{"key":"R32-8-20210130","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1161\/01.ATV.0000235691.84430.86","article-title":"Chemokines and incident coronary heart disease: results from the MONICA\/KORA Augsburg case-cohort study, 1984\u20132002","volume":"26","author":"Herder","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-8-20210130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.ATV.0000191633.52585.14","article-title":"Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers","volume":"26","author":"Rothenbacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-8-20210130","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.amjcard.2007.01.036","article-title":"Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study)","volume":"99","author":"Thakore","year":"2007","journal-title":"Am J Cardiol"},{"key":"R36-8-20210130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00001573-200311000-00008","article-title":"Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events","volume":"18","author":"Torres","year":"2003","journal-title":"Curr Opin Cardiol"},{"key":"R37-8-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2006.03.011","article-title":"Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction","volume":"115","author":"Tousoulis","year":"2007","journal-title":"Int J Cardiol"},{"key":"R38-8-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurheartj\/ehl361","article-title":"Association between plasma adiponectin levels and unstable coronary syndromes","volume":"28","author":"Wolk","year":"2007","journal-title":"Eur Heart J"},{"key":"R39-8-20210130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/diabetes.49.3.485","article-title":"Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study","volume":"49","author":"Jager","year":"2000","journal-title":"Diabetes"},{"key":"R40-8-20210130","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/ndt\/15.10.1624","article-title":"Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: association with malnutrition, inflammation, and cardiovascular disease","volume":"15","author":"Stenvinkel","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R41-8-20210130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cellimm.2008.04.015","article-title":"HIV-1 Tat protein induces IL-10 production by an alternative TNF-alpha-independent pathway in monocytes: role of PKC-delta and p38 MAP kinase","volume":"253","author":"Leghmari","year":"2008","journal-title":"Cell Immunol"},{"key":"R42-8-20210130","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.yexcr.2006.08.008","article-title":"Extracellular HIV-1 Nef increases migration of monocytes","volume":"312","author":"Lehmann","year":"2006","journal-title":"Exp Cell Res"},{"key":"R43-8-20210130","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1161\/STROKEAHA.106.479030","article-title":"The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection","volume":"38","author":"Coll","year":"2007","journal-title":"Stroke"},{"key":"R44-8-20210130","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1523\/JNEUROSCI.0061-08.2008","article-title":"Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling","volume":"28","author":"Zhong","year":"2008","journal-title":"J Neurosci"},{"key":"R45-8-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld","year":"1989","journal-title":"Am J Med"},{"key":"R46-8-20210130","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R47-8-20210130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/07853890009011772","article-title":"Function of C-reactive protein","volume":"32","author":"Du Clos","year":"2000","journal-title":"Ann Med"},{"key":"R48-8-20210130","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200905150-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:08:22Z","timestamp":1618038502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200905150-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,15]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32832995fa","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5,15]]}}}